- 1National Research Council of Italy, Institute for Biomedical Research and Innovation, Palermo, Italy
- 2National Research Council of Italy, Institute of Clinical Physiology, Pisa, Italy
- 3Department of Experimental Embryology, Institute of Genetics and Animal Breeding of the Polish Academy of Sciences, Jastrzebiec, Poland
Industrial areas are characterized by the dispersion of environmental stressors that could possibly have long-term detrimental effects on both human health and the environment. Environmental contamination has been indicated to be one of the major risks for reproductive health. In this context, the effects of environmental pollution on pregnant women living in heavily polluted areas is of special interest. In fact, fetal development is a crucial phase due to the dynamic interaction between the maternal/external environments and the developing organs and tissues. Moreover, following Barker's postulate of the intrauterine origin of health and disease, the events occurring in this time window could affect future health. Birth cohorts provide the most suitable design for assessing the association between early-life and possible long-term health outcomes in highly contaminated sites. By providing an assessment of the early life environment throughout the collection of biological samples, birth cohorts offer the opportunity to study in-depth several possible confounders and outcomes by means of questionnaires and follow-ups based on clinical evaluations and bio-specimen samplings. The exposome comprises the totality of exposures from conception onwards; the birth cohort approach allows the integration of the exposures as a whole, including those related to socioeconomic status, with “omics” data from biological samples collected at birth and throughout life. In the characterization of the “fetal exposome,” the placenta represents a highly informative and scarcely considered organ. For this purpose, the “Neonatal Environment and Health Outcomes” (NEHO) birth cohort has been established by enrolling pregnant women residing in contaminated sites and in surrounding areas.
Introduction
Health Effects of Environmental Exposures in Highly Contaminated Sites
Contaminated sites can be defined as “areas hosting or having hosted human activities which have produced or might produce environmental contamination of soil, surface or groundwater, air, food-chain, resulting or being able to result in human health impacts” (1). Contaminants such as heavy metals (HMs) and persistent organic pollutants (POPs) may transfer from one environmental matrix to another and, depending on their chemical-physical properties, are able to infiltrate the human body through different exposure pathways and routes (2). Living near environmental hazards contributes to a poorer general health status (3). Moreover, contaminated sites are often located in socially deprived neighborhoods; this makes exposure patterns more complex and results in interactions with other health determinants (4). Environmental pollution is one of the largest causes of death and disability in the world. In 2015, about 16% of premature deaths worldwide were caused by exposure to chemicals released into the environment (5). The WHO highlighted that 26% of deaths among children under five are due to modifiable environmental factors, and therefore can be prevented (6). Moreover, many childhood morbidities and disabilities are attributable to environmental causes and to gene-environment interaction starting from the fetal development period (7).
Environmental contamination is one of the major risk factors for reproductive health (8). Indeed, causal relationships between parental or prenatal environmental exposures and several adverse pregnancy and childhood outcomes have been clearly documented (9–13). Moreover, toxicants were associated with intrauterine growth restriction (14–16), inadequate birth weight (17), and premature births (18). These birth outcomes are of special interest for their double significance: they represent both an adverse outcome per se and could be considered as risk factors for future childhood pathologies.
Many chemicals released into the environment due to industrial processes are able to disrupt the programming of endocrine signaling. Thus, gametes, pregnant women, and developing fetuses are particularly vulnerable to the harmful impact of these environmental toxicants (19–21). For example, cadmium (Cd) has been identified as an endocrine disruptor and is released by industrial plants, negatively influencing both male and female reproductive health, acting at the level of the hypothalamic-pituitary-gonadal intercommunication axis (22). Lastly, human studies have shown an association between Cd exposure during pregnancy and low birth weight (23).
There is growing evidence supporting the hypothesis that prenatal exposure to toxicants is associated with long-term effects on children's neurological development (24, 25), respiratory and cardiovascular systems (26), and metabolic signaling (27). For instance, children born to women exposed to organochlorine pesticides have a higher risk of developing neurodevelopmental, neurodegenerative, and neurobehavioral disorders (28, 29). Prenatal exposure to methylmercury has also been associated with the development of autism spectrum disorders (30). Similarly, a significant increase in the incidence of “bronchitis” was reported in Taiwanese children born to women exposed to polychlorinated biphenyls (PCBs) during pregnancy (31). Moreover, prenatal exposure to perfluoroalkyl substances and postnatal exposure to copper, ethylparaben, and household crowding were associated with poorer lung function in 6- and 12-year-old children (32). In-utero exposure to hexachlorobenzene (HCB) and dichlorodiphenyldichloroethylene (DDE) was associated with childhood obesity and higher blood pressure levels at 4 years (33). In this study, an obesogenic effect of DDE and HCB was hypothesized through sex steroid dysregulation. Moreover, in a French birth cohort, an association was found between high maternal Cd and lead (Pb) blood levels and increased risk of gestational diabetes (34). Fetal exposure to maternal gestational diabetes was further associated with an altered glucose-induced hypothalamic activity in children and, as a consequence, with increased risk of obesity later in life (35).
Scientific data on the long-term effects of developmental exposures provide new insight into the importance of preventing the negative effects of environmental chemicals on the residents of highly polluted sites. There are different methodologies to assessing pollutant impacts on human health through studies with both ecological and etiological design. One example is the SENTIERI Project, which works toward multiple endpoints, including hospital discharges during infancy and congenital anomalies, in all the main contaminated sites in Italy, implementing an a-priori identification of health endpoints linked with pollution sources (36). This approach is of undeniable value for public health monitoring, even though any demonstration of pathophysiological links between environmental pollutants and health effects requires further research.
It is generally recognized that prospective pregnancy or birth cohort studies, incorporating exposure biomarkers during sensitive windows, are required to examine the potential health effects of developmental exposure to chemicals. Birth cohort studies provide the most suitable design for assessing the association of early-life adversities occurring at critical developmental windows with their possible long-lasting effects on postnatal health and well-being. Cohort populations living in highly contaminated sites have been studied mainly in occupational settings; in contrast, their use in the general population is not well-represented in scientific literature, though remarkable examples are available, especially in cases of accidental events, such as the Seveso disaster (37) or Minamata disease (38).
Fetal Development and Environmental Epidemiology
Starting from Barker's postulate of the “intrauterine origins of health and disease susceptibility” (39–41), growing evidence has highlighted how environmental stressors can interfere with the early stages of fetal development leading to diseases later in life. Chemical compounds, social stress, and lifestyle can lead to the permanent alteration of fetal development, possibly resulting in increased susceptibility to adverse health outcomes over a person's lifetime (42, 43). Homeostatic processes during fetal life allow the organism to dynamically adapt to changes in the intrauterine environment in order to obtain an immediate survival chance and to have future adaptive advantages in adulthood (44). However, changes that turn out to be adaptive for one endpoint, such as surviving an acute stressful condition, may be maladaptive in other life stages, thus producing a higher risk of non-communicable disease occurrence (45).
In recent years, the role of epigenetic mechanisms (e.g., nucleotide and histone chemical modifications and small non-coding RNAs) has been recognized in regulating fetal development and its adaptation to changing environmental conditions through changing gene expression (45), while growing evidence has drawn attention to epigenetic alterations induced by environmental contaminants (46). Epigenetic alterations that affect the trajectories of fetal development may maintain their effects over generations (47). Industrial activities and power plants are known sources of many chemicals which can induce epigenetic effects (2, 48–52). DNA methylation is a potential mechanism by which environmental exposures may contribute to the etiology of complex diseases (53). Epigenetic changes have been observed in pregnant women, placentas, and cord blood after exposure to various environmental contaminants, such as phthalate and bisphenol A (54), but also to maternal smoking (55) and psychological stress (56). In a large-scale epigenome-wide meta-analysis, the authors found a significant association of PM10 and PM2.5 exposures during pregnancy with methylation differences in newborns' genes relevant to respiratory health, such as FAM13A and NOTCH4 (57).
Pregnant women living in highly contaminated sites can be exposed via multiple pathways, including food, inhalation, and dermal contact. The exposure of the developing fetus to environmental contaminants may lead to multi-organ alterations producing organ dysfunction and diseases. Toxicants influence fetal development in different ways. The influence can be direct, as in the case of arsenic (As), Pb, and mercury (Hg) as these substances can readily pass through the placenta into the fetal environment (58), or indirect, as in the case of Cd, by interfering with maternal and placental homeostatic functions leading in turn to altered signaling with the fetus (Figure 1). For other environmental toxicants, such as PCBs, their ability to pass through the placenta is related to congener specific chemical-physical properties, such as molecular weight and lipophilicity (59).
Figure 1. Schematic representation of direct and indirect interactions among environmental stressors, placental domain, and possible negative health outcomes. HMs, heavy metals; POPs, persistent organic pollutants.
Many studies performed in highly contaminated areas have evaluated residential proximity to pollution sources or air pollutant exposures (11, 60–63). On the contrary, studies on the contribution of soil and water contamination to human exposure, as well as those related to the food chain and human biomonitoring, are less represented in scientific literature (64–66).
Recently, Heindel and colleagues published a comprehensive review of epidemiological studies evaluating associations between in-utero and early post-natal life exposure to environmental chemicals and adverse health outcomes (67). They examined 425 papers, showing that most of the publications were related to neurological/cognitive outcomes, followed by cancer and respiratory diseases. Only in recent years have researchers focused on metabolic outcomes (including obesity) and second generation reproductive health (67). Similarly, studies in highly contaminated sites have indicated a greater incidence and prevalence of a variety of health conditions, including cancer, respiratory diseases, diabetes, obesity, and negative reproductive health outcomes (68, 69). Moreover, in Heindel's review, more than 60 different chemical compounds were identified, most of which are known to be related to environmental contamination due to power plants and industrial/petrochemical emissions. The most frequently studied chemicals are PCBs, often associated with incineration and power generation processes (70). Regarding heavy metals, Hg, Pb, and As were the most represented in the review. In Table 1, a short list of studies on environmental pollutants present in highly polluted areas is reported along with the relevant health outcomes in pediatric age (71–98).
Table 1. Selected list of studies on environmental pollutants performed in pediatric age in highly polluted areas, along with the relevant health outcomes.
However, people living in heavily contaminated areas present a different exposure profile as compared to the general population, in terms of both level of exposure and number of contaminated environmental matrices. In this respect, multipollutant models are designed to overcome the difficulty of identifying effects of multiple pollutants in epidemiological studies which also try to effectively capture the health impact of pollution mixtures observed under real-life conditions. These models are of particular interest, though scarcely represented, especially in the context of highly contaminated sites. Moreover, the evaluation of real-life exposure represents a methodological challenge for the overall integration of exposure measures obtained from different matrices (e.g., ambient air, blood, tissues).
The Fetal Exposome and the Placenta
Omics, including genome, epigenome, transcriptome, metabolome, and microbiome, have widened our ability to investigate complex biological processes. The possibility of considering multiple molecular pathways at once gives us the opportunity to have a more holistic and comprehensive understanding of an organism's development and functions. Along the same line, Christopher Paul Wild coined the term “exposome” in order to promote the use of an omics approach in the field of environmental epidemiology (99).
Consistent advances have been made in “measuring” the levels of environmental contaminants in biological tissues; however, a delineated exposome approach has not been applied in clinical settings. The exposome not only concerns toxic chemicals but also includes three domains: (1) a general external domain including the social and economic context and stress factors; (2) a specific external domain including environmental pollutants, diet, and drugs; and (3) a specific internal domain including biomarkers of exposure, effects, and susceptibility (100). Another key concept in defining the exposome is its dynamic nature (100): for example, changes in household, school, occupation, socioeconomic profile, social interactions and stress, course of medical treatment, exposure profile (even for a short period), and migration flows may all produce changes in the exposome during a lifetime and should be measured over time. Therefore, the full characterization of an individual's exposome requires a number of measures able to capture exposure during their lifespan. However, individual susceptibility changes with age, and specific time windows can be identified.
As discussed above, fetal life is one of the crucial time windows during which future health takes shape through a dynamic interaction between the maternal/external environments and developing organs and tissues (Figure 2). In this context, the effort to characterize the fetal exposome is a priority for determining future health and disease predisposition.
Figure 2. Graphical representation of the relationships among development phases, genetic predisposition, and environmental stressor factors that may interfere with regulatory mechanisms during the early stages of life (from in utero development to puberty).
The placenta, as a sort of gestational logbook, is a useful organ for defining the exposome, as well as a valid target organ for molecular biomarkers. In fact, the placenta plays a key role in the maintenance of an adequate intrauterine environment as well as in signal transmissions from the fetus to the mother and vice versa (101). Nutrition supplies, gas exchange, endocrine, and immune regulation are guaranteed by the placenta. At the same time, it has a pivotal role in minimizing the quantity of environmental contaminants, toxins, pathogens, and maternal stress hormones reaching the fetus (102). Placental development begins during the first few weeks after fertilization; from this moment, the success of fetal development is dependent on an appropriate placentation and on the remodeling of maternal circulation to ensure its perfusion (103). Moreover, environmental toxicants from maternal blood can reach the fetus only by passing through the placenta, which is known to be a selective barrier (104). Placental cells express detoxification enzymes and antioxidant molecules which are involved in fetal protection against toxicants and free oxygen radicals (105). On the other hand, those chemicals which do not pass the placental barrier may accumulate in placental tissue, thus modifying its functions and indirectly affecting the fetus. The placenta is usually discarded after birth and can be sampled in a non-invasive procedure. It has been previously defined as a “black-box” event recorder due to its highly informative potential for summarizing the in-utero experience (106). From this point of view, placental multi-omics investigation (e.g., epigenomics, transcriptomics, and proteomics) could be considered an essential step for simultaneously testing exposure, effects, and susceptibility biomarkers in a single biological matrix—i.e., a valid proxy for the internal fetal exposome.
For example, with respect to placental exposure biomarkers, studies have shown that placental levels of Cd correlate to the expression levels of the Metallothionein gene (107). Another study found that placental expression of the arsenic transporter AQP9 was positively associated with maternal urinary As levels during pregnancy (108). However, these studies consider placental gene expression for exposure to a single pollutant. Only a few studies have tried to investigate two (109) or more co-exposures and their potential effects on placental physiology or functions (110). Deyssenroth and colleagues proposed an exposure regression analysis to derive metal mixture indices associated with placental networks, which in turn are associated with small-for-gestational age (SGA) status. They found that, among 19 metals tested, As and Cd levels are associated with SGA, and the effects of these metals persist even after accounting for the presence of correlated co-pollutants (110).
With regards to biomarkers of possible effects, in a study conducted by Ahmed and colleagues, a reduction in levels of placental T cells and alterations of cord blood cytokine concentrations were observed in a Bangladeshi population associated with high maternal As exposure (111). Along the same line, Lambertini et al. (112) detected a placental-specific imprinted gene expression panel associated with both maternal psychosocial stress during pregnancy and birthweight. The same authors, in a previous work, also showed that alterations of placental imprinted gene expression were associated with suboptimal perinatal growth and responsive to exposure to PCBs and DDE (113). Finally, in a recent epigenome-wide study, Maccani et al. identified evidence of hypomethylation of the EMID2 gene in association with in-utero Hg exposure. This altered methylation status was also found to be linked to adverse neurobehavioral outcomes during infancy (114).
In addition to data from placental examination and the bio-monitoring of multiple pollutants in maternal and cord blood (internal exposome), maternal data collected through questionnaires (diet, physical activity, lifestyle, stress factors, socio-demographic characteristics, and use of medication during pregnancy) and geo-spatial data associated with environmental monitoring stations could be used to define the external fetal exposome (both general and specific) and its association with postnatal health outcomes.
In the context of a highly polluted site, cohort studies concerning the fetal exposome may be useful for describing the complexity of chronic multi-toxicant exposure, socioeconomic determinants, and maternal life-style habits and their combined effects on the derived population of children. In the case of heavily contaminated sites, social and physical environmental toxicants tend to cluster in the most socially disadvantaged populations (115); thus, a better understanding of these complex interdependencies may help to prevent health disparities. Socioeconomic status during childhood has been found to have greater influence on adult DNA methylation profiles than socioeconomic status during adult life (116). Moreover, dietary lifestyle and micronutrient supplementation may play a role in maintaining DNA stability (117). Nevertheless, the studies on the combined effects of lifestyles/socioeconomic determinants and environmental pollutants are poorly represented in the literature. Indeed, it is well-established that maternal stress increases blood cortisol levels. The placenta is able to reduce the amount of cortisol that can reach the fetus through the 11β-HSD2 enzyme (118). At the same time, exposure to Cd influences the expression and activity of placental 11β-HSD2 (119). Thus, the contemporary presence of stressful conditions during pregnancy and Cd exposure can irreversibly affect the hypothalamic-pituitary-adrenal axis via fetal exposure to cortisol. Another example of the joint effects of the social and physical environment includes the interaction between NO2 air exposure and elevated social stress on increasing risk for childhood asthma (120).
Finally, it is essential to produce consistent data to uncover the fetal developmental windows and molecular pathways most vulnerable to the negative influence of toxicants. Discovering specific biomarkers of prenatal exposure, which may be predictive for the child health outcomes, will increase our ability to develop early diagnostic and prophylactic/therapeutic tools to be applied in pregnant women residing in highly contaminated areas.
Existing Birth Cohorts on Prenatal Exposome and Methodological Aspects
Highly contaminated sites often present serious environmental contamination scenarios, where pollutants can persist in the environment for decades even after pollution sources are removed. Moreover, in these areas, interaction between environmental pollutants and other health determinants, such as social stress, poverty, and limited access to medical services, may coexist (121). To date, the need to reduce environmental exposures has been widely highlighted, focusing on the close link between human health and the environment, as well as the possible large-scale economic return (122). Birth cohorts are an approach allowing the integration of the exposures as a whole, including those related to socioeconomic status, with “omics” data from biological samples collected at birth and throughout life. One of the major advantages provided by birth cohort design is the assessment of the early life environment, studying in-depth several possible confounders and outcomes by means of questionnaires, follow-ups based on clinical evaluation, and biological samples collected at different time points.
The Project on Human Early Life Exposome—HELIX is the first attempt at developing a multistep statistical analysis approach based on different tools and methods, also integrating “omics” into the exposome. To do this, HELIX pooled six existing longitudinal population-based birth cohort studies in Europe, measuring the external exposome (individual and outdoor exposures), integrating the external and internal exposome (integrating molecular exposure signatures), and evaluating the impact of the early-life exposome on child health (also including the effect of multiple exposures) (32). HELIX measured over 200 single environmental exposures of concern for child health, allowing a detailed analysis of the structure of the early life exposome, including its correlations, patterns, and variability (123). On the same emerging line, the Project Health and Environment-wide Associations based on Large Population Surveys—HEALS was aimed at identifying the complex links among genes, environment, and many human diseases by means of a large collaborative action among existing cohorts in Europe (124).
Recently, Sarigiannis and Karakitsios, in the context of COST Action IS1408 on “Industrially Contaminated Sites and Health Network,” developed a model for the characterization of the exposome in children living close to a very large landfill area (125). With a design especially developed for a highly contaminated area, this project is an attempt to use the exposome paradigm to better understand the relationships that exist among the co-determinants of exposures and its effects on the health of exposed individuals and their progeny.
The exposure of pregnant women to environmental contaminants present in highly contaminated areas can severely impact the wellbeing of future generations. The Italian International Centre of Advanced Study in Environment, Ecosystem and Human Health (CISAS) project is aimed at understanding the chemical-physical and biological processes that regulate the distribution of contaminants in various environmental matrices, as well as their transfer to the ecosystem and the human body and consequent health sequelae (126). In the context of the CISAS project, the “Neonatal Environment and Health Outcomes” (NEHO) birth cohort has been established by enrolling pregnant women residing in these contaminated sites and in surrounding areas. The CISAS project evaluates pollutants in all the environmental matrices (air, soil, sediment, inland waters, and sea) as well as the food chain (fish, meat, eggs, milk, and dairy products, sampled from local producers of each evaluated area) within three heavily contaminated sites in southern Italy: two widely industrialized coastal sites characterized by petrochemical complexes and power plants and one disused industrial area. Environmental data will be linked to georeferenced maternal residences, also taking into account possible daily commuting to work. The NEHO questionnaires collect information on maternal pre-pregnancy and gestational health status, lifestyle, and socio-demographic characteristics, along with smoking habits and possible chemical exposures. The protocol includes the collection of maternal and cord blood, along with placental tissue at delivery (126). In the context of the NEHO cohort, measurements of the levels of toxicants will be taken from maternal and cord blood as well as the placenta. Because the placenta has an active role in fetal development, and the impairment of placental formation, differentiation, and/or function may affect fetal development, in the context of the NEHO cohort we will investigate the relationship between exposure to environmental toxic compounds (both HMs and POPs) and shifts in gene expression by means of a whole transcriptome analysis. Finally, follow up of the offspring will be conducted to uncover the possible consequences of specific toxicants. The follow-up on children will allow the evaluation of the possible relationship between the fetal exposome and long-term health outcomes. To this aim, after delivery, information is collected on newborns regarding use of medicine, characteristics of home environments, breastfeeding and nutritional outcomes (including growth), respiratory disease, metabolic disorders, neurocognitive development, infections and injuries, and hospitalizations (also collecting hospital discharge records). The main objectives of the NEHO cohort are: (1) to understand processes and mechanisms for the transfer of HMs and POPs from the environment and the ecosystem to the developing fetus, (2) discover specific placental biomarkers informative of fetal exposure, and (3) identify possible primary intervention strategies aimed at reducing fetal exposure. The implementation of these milestones could have an impact on the early detection of negative outcomes during childhood based on placental omics, as well as on our ability to prioritize intervention strategies.
Conclusions
The fourth session of the United Nations Environment Assembly of the UN Environment Programme, Nairobi 2019, recommended increasing efforts to overcome common health-related challenges as well as addressing the role of pollution as a cause of disease (127). Accordingly, the health of pregnant women in heavily polluted areas is an absolute priority for public health strategies.
To this end, in our opinion, the use of birth cohorts in heavily polluted areas represents a great opportunity for a better comprehension of the mechanisms underlying the relationship between environment and human health, adopting the in-utero developmental phase as a useful time window for identifying the origin of health and disease in childhood and adult life. In this context, the human placenta represents a useful matrix for exploring fetal exposure to environmental contaminants and possible predisposition to adverse health effects later in life.
Author Contributions
SR, GD, FB, SS, and FC made substantial contributions to the conceptualization and design of the study. SR, GD, FB, and FC are involved in study monitoring. All authors drafted and critically revised the manuscript for its content, and gave final approval of the version to be published.
Funding
The CISAS project is a multidisciplinary project on environment/health relationships funded by the Italian Ministry of Education, Universities and Research (MIUR) and approved by the Interministerial Committee for Economic Planning (CIPE) – a body of the Italian government – with Resolution no. 105/2015 of December 23, 2015.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
The NEHO cohort has been developed as part of a scientific collaboration among the National Research Council of Italy - Institute for Biomedical Research and Innovation, Palermo; the Department of Epidemiology, Lazio - Regional Health System, Rome; and the Epidemiology Unit, Anna Meyer Children's University Hospital, Florence.
We also thank Dott. Iacopo Sorrentino for his kind technical help in bibliographic research.
References
1. Martuzzi M, Pasetto R, Martin-Olmedo P. Industrially contaminated sites and health. J Environ Public Health. (2014) 2014:198574. doi: 10.1155/2014/198574
2. Panagos P, Van Liedekerke M, Yigini Y, Montanarella L. Contaminated sites in Europe: review of the current situation based on data collected through a European network. J Environ Public Health. (2013) 2013:1–11. doi: 10.1155/2013/158764
3. Brender JD, Maantay JA, Chakraborty J. Residential proximity to environmental hazards and adverse health outcomes. Am J Public Health. (2011) 101(Suppl. 1):S37–52. doi: 10.2105/AJPH.2011.300183
5. Landrigan PJ, Fuller R, Acosta NJR, Adeyi O, Arnold R, Basu NN, et al. The Lancet Commission on pollution and health. Lancet. (2018) 3:462–512. doi: 10.1016/S0140-6736(17)32345-0
6. Prüss-Ustün A, Wolf J, Corvalán C, Bos R, Neira M. Preventing Disease Through Healthy Environments: A Global Assessment of the Burden of Disease From Environmental Risks. Geneva: WHO (2016) Available online at: http://apps.who.int/iris/bitstream/10665/204585/1/9789241565196_eng.pdf (accessed April 2020).
7. WHO. Inheriting a Sustainable World? Atlas on Children's Health and the Environment. Geneva: World Health Organization (2017).
8. Jasienska G, Bribiescas RG, Furberg AS, Helle S, Núñez-de la Mora A. Human reproduction and health: an evolutionary perspective. Lancet. (2017) 29:510–20. doi: 10.1016/S0140-6736(17)30573-1
9. Baldacci S, Gorini F, Santoro M, Pierini A, Minichilli F, Bianchi F. Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiological evidence. Epidemiol Prev. (2018) 42(Suppl. 1):1–34. doi: 10.19191/EP18.3-4.S1.P001.057
10. Castelló A, Río I, García-Pérez J, Fernández-Navarro P, Waller LA, Clennon JA, et al. Adverse birth outcomes in the vicinity of industrial installations in Spain 2004–2008. Environ Sci Pollut Res Int. (2013) 20:4933–46. doi: 10.1007/s11356-012-1444-5
11. Dummer TJB, Dickinson HO, Parker L. Prevalence of adverse pregnancy outcomes around hazardous industrial sites in Cumbria, north-west England, 1950–93. Paediatr Perinat Epidemiol. (2003) 17:250–5. doi: 10.1046/j.1365-3016.2003.00495.x
12. Bhopal RS, Tate JA, Foy C, Moffatt S, Phillimore PR. Residential proximity to industry and adverse birth outcomes. Lancet. (1999) 354:920–21. doi: 10.1016/S0140-6736(99)01687-6
13. Shah PS. Paternal factors and low birthweight, preterm, and small for gestational age births: a systematic review. Am J Obstet Gynecol. (2010). 202:103–23. doi: 10.1016/j.ajog.2009.08.026
14. Pedersen M, Giorgis-Allemand L, Bernard C, Aguilera I, Andersen AM, Ballester F, et al. Ambient air pollution and low birthweight: a European cohort study (ESCAPE). Lancet Respir Med. (2013) 1:695–704. doi: 10.1016/S2213-2600(13)70192-9
15. Wigle DT, Arbuckle TE, Turner MC, Berube A, Yang Q, Liu S, et al. Epidemiologic evidence of relationships between reproductive and child health outcomes and environmental chemical contaminants. J Toxicol Environ Health B Crit Rev. (2008) 11:373–517 doi: 10.1080/10937400801921320
16. Ballester F, Estarlich M, Iniguez C, Llop S, Ramon R, Esplugues A, et al. Air pollution exposure during pregnancy and reduced birth size: a prospective birth cohort study in Valencia, Spain. Environ Health. (2010) 9:6. doi: 10.1186/1476-069X-9-6
17. Wang A, Padula A, Sirota M, Woodruff TJ. Environmental influences on reproductive health: the importance of chemical exposures. Fertil Steril. (2016) 106:905–29. doi: 10.1016/j.fertnstert.2016.07.1076
18. Llop S, Ballester F, Estarlich M, Esplugues A, Rebagliato M, Iniguez C. Preterm birth and exposure to air pollutants during pregnancy. Environ Res. (2010) 110:778–85. doi: 10.1016/j.envres.2010.09.009
19. Caserta D, Mantovani A, Marci R, Fazi A, Ciardo F, La Rocca C, et al. Environment and women's reproductive health. Hum Reprod Update. (2011) 17:418–33. doi: 10.1093/humupd/dmq061
20. Vecoli C, Montano L, Andreassi MG. Environmental pollutants: genetic damage and epigenetic changes in male germ cells. Environ Sci Pollut Res Int. (2016) 23:23339–48. doi: 10.1007/s11356-016-7728-4
21. Shah PS, Balkhair T. Knowledge synthesis group on determinants of preterm/LBW births. air pollution and birth outcomes: a systematic review. Environ Int. (2011) 37:498–516. doi: 10.1016/j.envint.2010.10.009
22. Interdonato M, Pizzino G, Bitto A, Galfo F, Irrera N, Mecchio A, et al. Cadmium delays puberty onset and testis growth in adolescents. Clin Endocrinol. (2015) 83:357–62. doi: 10.1111/cen.12704
23. Frery N, Nessmann C, Girard F, Lafond J, Moreau T, Blot P, et al. Environmental exposure to cadmium and human birthweight. Toxicology. (1993) 79:109–18. doi: 10.1016/0300-483X(93)90124-B
24. Calderón-Garcidueñas L, Leray E, Heydarpour P, Torres-Jardón R, Reis J. Air pollution, a rising environmental risk factor for cognition, neuroinflammation and neurodegeneration: the clinical impact on children and beyond. Rev Neurol. (2016) 172:69–80. doi: 10.1016/j.neurol.2015.10.008
25. Porta D, Narduzzi S, Badaloni C, Bucci S, Cesaroni G, Colelli V, et al. Air pollution and cognitive development at age 7 in a prospective Italian birth cohort. Epidemiology. (2016) 27:228–36. doi: 10.1097/EDE.0000000000000405
26. Gascon M, Morales E, Sunyer J, Vrijheid M. Effects of persistent organic pollutants on the developing respiratory and immune systems: a systematic review. Environ Int. (2013) 52C:51–65. doi: 10.1016/j.envint.2012.11.005
27. Thayer KA, Heindel JJ, Bucher JR, Gallo MA. Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review. Environ Health Perspect. (2012) 120:779–89. doi: 10.1289/ehp.1104597
28. Dietert RR, Dietert JM, Dewitt JC. Environmental risk factors for autism. Emerg Health Threats J. (2011) 4:7111. doi: 10.3402/ehtj.v4i0.7111
29. Saeedi Saravi SS, Dehpour AR. Potential role of organochlorine pesticides in the pathogenesis of neurodevelopmental, neurodegenerative, and neurobehavioral disorders: a review. Life Sci. (2016) 145:255–64. doi: 10.1016/j.lfs.2015.11.006
30. Van Wijngaarden E, Davidson PW, Smith TH, Evans K, Yost K, Love T, et al. Autism spectrum disorder phenotypes and prenatal exposure to methylmercury. Epidemiology. (2013) 24:651–9. doi: 10.1097/EDE.0b013e31829d2651
31. Rogan W, Gladen B, Hung K, Koong S, Shih L, Taylor J, et al. Congenital poisoning by polychlorinated biphenyls and their contaminants in Taiwan. Science. (1988) 15 241:334–6. doi: 10.1126/science.3133768
32. Agier L, Basagaña X, Maitre L, Granum B, Bird PK, Casas M, et al. Early-life exposome and lung function in children in Europe: an analysis of data from the longitudinal, population-based HELIX cohort. Lancet Planet Health. (2019) 3:81–92. doi: 10.1016/S2542-5196(19)30010-5
33. Vafeiadi M, Georgiou V, Chalkiadaki G, Rantakokko P, Kiviranta H, Karachaliou M, et al. Association of prenatal exposure to persistent organic pollutants with obesity and cardiometabolic traits in early childhood: the rhea mother–child cohort (Crete, Greece) Environ Health Perspect. (2015) 123:1015–21. doi: 10.1289/ehp.1409062
34. Soomro MH, Baiz N, Huel G, Yazbeck C, Botton J, Heude B, et al. Exposure to heavy metals during pregnancy related to gestational diabetes mellitus in diabetes-free mothers. Sci Total Environ. (2019) 656:870–6. doi: 10.1016/j.scitotenv.2018.11.422
35. Page KA, Luo S, Wang X, Chow T, Alves J, Buchanan TA, et al. Children exposed to maternal obesity or gestational diabetes mellitus during early fetal development have hypothalamic alterations that predict future weight gain. Diabetes Care. (2019) 42:1473–80. doi: 10.2337/dc18-2581
36. Zona A, Iavarone I, Buzzoni C, Conti S, Santoro M, Fazzo L, et al. Sentieri epidemiological study of residents in national priority contaminated sites. Fifth report. Epidemiol Prev. (2019) 43(2–3 Suppl. 1):1–208. doi: 10.19191/EP19.2-3.S1.032
37. Mocarelli P. Seveso: a teaching story. Chemosphere. (2001) 43:391–402. doi: 10.1016/s0045-6535(00)00386-6
38. Yorifuji T, Kato T, Kado Y., Tokinobu A, Yamakawa M, Tsuda T, et al. Intrauterine exposure to methylmercury and neurocognitive functions: minamata disease. Arch. Environ. Occup. Health. (2015) 70:297–302. doi: 10.1080/19338244.2014.904268
39. Barker DJ, Osmond C, Winter PD. Weight in infancy and death from ischaemic heart disease. Lancet. (1989) 2. 577–80. doi: 10.1016/S0140-6736(89)90710-1
40. Barker DJ. Maternal nutrition, fetal nutrition and disease in later life. Nutrition. (1997) 13:807–13. doi: 10.1016/S0899-9007(97)00193-7
41. Barker DJ. The origins of the developmental origins theory. J Intern Med. (2007) 261:412–7. doi: 10.1111/j.1365-2796.2007.01809.x
42. Barouki R, Gluckman PD, Grandjean P, Hanson M, Heindel JJ. Developmental origins of non-communicable disease: implications for research and public health. Environ Health. (2012) 11:42–3. doi: 10.1186/1476-069X-11-42
43. Gluckman PD, Hanson MA, Mitchell MD. Developmental origins of health and disease: reducing the burden of chronic disease in the next generation. Genome Med. (2010) 24:14. doi: 10.1186/gm135
44. Gluckman PD, Hanson MA. The developmental origins of the metabolic syndrome. Trends Endocrinol Metab. (2004) 15:183. doi: 10.1016/j.tem.2004.03.002
45. Sharp D. Book of the month: the fetal matrix: evolution, development and disease. J R Soc Med. (2005) 98:130–31. doi: 10.1177/014107680509800314
46. Heijmans BT, Tobi EW, Lumey LH, Slagboom PE. The epigenome: archive of the prenatal environment. Epigenetics. (2009) 4:526–31. doi: 10.4161/epi.4.8.10265
47. Drake A, Walker B. The intergenerational effects of fetal programming: non-genomic mechanisms for the inheritance of low birth weight and cardiovascular risk. J Endocrinol. (2004) 180:1–16. doi: 10.1677/joe.0.1800001
48. Wu Q, Ohsako S, Ishimura R, Suzuki JS, Tohyama C. Exposure of mouse preimplantation embryos to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters the methylation status of imprinted genes H19 and Igf2. Biol Reprod. (2004) 70:1790–7 doi: 10.1095/biolreprod.103.025387
49. Hu J, Yu Y. Epigenetic response profiles into environmental epigenotoxicant screening and health risk assessment: a critical review. Chemosphere. (2019) 226:259–72. doi: 10.1016/j.chemosphere.2019.03.096
50. Zhu H, Li K, Liang J, Zhang J, Wu Q. Changes in the levels of DNA methylation in testis and liver of SD rats neonatally exposed to 5-aza-2'-deoxycytidine and cadmium. J Appl Toxicol. (2011) 31:484–95. doi: 10.1002/jat.1673
51. Hanna CW, Bloom MS, Robinson WP, Kim D, Parsons PJ, Vom Saal FS, et al. DNA methylation changes in whole blood is associated with exposure to the environmental contaminants, mercury, lead, cadmium and bisphenol A, in women undergoing ovarian stimulation for IVF. Hum Reprod. (2012) 27:1401–10. doi: 10.1093/humrep/des038
52. Kile ML, Baccarelli A, Hoffman E, Tarantini L, Quamruzzaman Q, Rahman M, et al. Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord blood leukocytes. Environ Health Perspect. (2012) 120:1061–6. doi: 10.1289/ehp.1104173
53. Skinner MK. Role of epigenetics in developmental biology and transgenerational inheritance. Birth Defects Res C Embryo Today. (2011) 93:51–5. doi: 10.1002/bdrc.20199
54. Strakovsky RS, Schantz SL. Impacts of bisphenol A (BPA) and phthalate exposures on epigenetic outcomes in the human placenta. Environ Epigenet. (2018) 4:dvy022. doi: 10.1093/eep/dvy022
55. Everson TM, Vives-Usano M, Seyve E, Cardenas A, Lacasaña M, Craig JM, et al. Placental DNA methylation signatures of maternal smoking during pregnancy and potential impacts on fetal growth. bioRxiv [Preprint]. (2019) bioRxiv:663567. doi: 10.1101/663567
56. DeSocio JE. Reprint of “Epigenetics, maternal prenatal psychosocial stress, and infant mental health.” Arch Psychiatr Nurs. (2019). 33:232–7. doi: 10.1016/j.apnu.2019.05.001
57. Gruzieva O, Xu C-J, Yousefi P, Relton C, Merid SK, Breton CV, et al. Prenatal particulate air pollution and DNA methylation in newborns: an epigenome-wide meta-analysis. Environ Health Perspect. (2019) 127:057012. doi: 10.1289/EHP4522
58. Iyengar G, Rapp A. Human placenta as a ‘dual' biomarker for monitoring fetal and maternal environment with special reference to potentially toxic trace elementsPart 1: Physiology, function and sampling of placenta for elemental characterisation. Sci. Total Environ. (2001) 3:195–206. doi: 10.1016/S0048-9697(01)00825-7
59. Lancz K, Murínová L, Patayová H, Drobná B, Wimmerová S, Šovčíková E, et al. Ratio of cord to maternal serum PCB concentrations in relation to their congener-specific physicochemical properties. Int J Hyg Environ Heal. (2015) 218:91–8. doi: 10.1016/j.ijheh.2014.08.003
60. Svechkina A, Dubnov J, Portnov BA. Environmental risk factors associated with low birth weight: The case study of the Haifa Bay Area in Israel. Environ Res. (2018) 165:337–48. doi: 10.1016/j.envres.2018.05.006
61. Ha S, Hu H, Roth J, Kan H, Xu X. Associations between residential proximity to power plants and adverse birth outcomes. Am. J. Epidemiol. (2015) 182:215–24. doi: 10.1093/aje/kwv042
62. Mohorovic L. The level of maternal methemoglobin during pregnancy in an air-polluted environment. Environ Health Perspect. (2003) 111:1902–5. doi: 10.1289/ehp.6055
63. Oliveira LM, Stein N, Sanseverino MTV, Vargas VMF, Fachel JMG, Schüler L. Reproductive outcomes in an area adjacent to a petrochemical plant in southern Brazil. Rev. Saúde Pública. (2002) 36:81–7. doi: 10.1590/S0034-89102002000100013
64. Deroma L, Parpinel M, Tognin V, Channoufi L, Tratnik J, Horvat M, et al. Neuropsychological assessment at school-age and prenatal low-level exposure to mercury through fish consumption in an Italian birth cohort living near a contaminated site. Int J Hyg Environ Health. (2013) 216:486–93. doi: 10.1016/j.ijheh.2013.02.004
65. Grumetto L, Ortosecco G, Russo G, Guida M, Ferranti P, Nasi A, et al. Dioxin-like PCB levels in maternal and umbilical cord sera of people living near dump sites in southern Italy: a pilot study of biomonitoring. Environ Monit Assess. (2015) 187:88. doi: 10.1007/s10661-015-4267-2
66. Bergonzi R, Specchia C, Dinolfo M, Tomasi C, De Palma G, Frusca T, et al. Distribution of persistent organochlorine pollutants in maternal and foetal tissues: data from an Italian polluted urban area. Chemosphere. (2009) 76:747–54. doi: 10.1016/j.chemosphere.2009.05.026
67. Heindel JJ, Skalla LA, Joubert BR, Dilworth CH, Gray KA. Review of developmental origins of health and disease publications in environmental epidemiology. Reprod Toxicol. (2017) 68:34–48. doi: 10.1016/j.reprotox.2016.11.011
68. Colles A, Ardeleanu E-R, Candeias C, Ranzi A, Demeter Z, Kowalska M, et al. Human biomonitoring as a tool for exposure assessment in industrially contaminated sites (ICSs) - lessons learned within the ICS and health European network. Epidemiol Prev. (2019) 43:249–59. doi: 10.19191/EP19.4.A03.070
69. de Sario M, Pasetto R, Vecchi S, Zeka A, Hoek G, Michelozzi P, et al. A scoping review of the epidemiological methods used to investigate the health effects of industrially contaminated sites. Epidemiol Prev. (2018) 42:59–68. doi: 10.19191/EP18.5-6.S1.P059.088
70. Dyke PH, Foan C, Fiedler H. PCB and PAH releases from power stations and waste incineration processes in the UK. Chemosphere. (2003) 50:469–80. doi: 10.1016/S0045-6535(02)00627-6
71. Smith AH, Marshall G, Yuan Y, Ferreccio C, Liaw J, von Ehrenstein O, et al. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect. (2006) 114:1293–96. doi: 10.1289/ehp.8832
72. Jin X, Tian X, Liu Z, Hu H, Li X, Deng Y, et al. Maternal exposure to arsenic and cadmium and the risk of congenital heart defects in offspring. Reprod Toxicol. (2016) 59:109–16. doi: 10.1016/j.reprotox.2015.12.007
73. Suhl J, Leonard S, Weyer P, Rhoads A, Siega-Riz AM, Renée Anthony T, et al. Maternal arsenic exposure and nonsyndromic orofacial clefts. Birth Defects Res. (2018) 110:1455–67. doi: 10.1002/bdr2.1386
74. Wang B, Liu J, Liu B, Liu X, Yu X. Prenatal exposure to arsenic and neurobehavioral development of newborns in China. Environ Int. (2018) 121:421–7. doi: 10.1016/j.envint.2018.09.031
75. Rodríguez-Barranco M, Lacasaña M, Aguilar-Garduño C, Alguacil J, Gil F, González-Alzaga B, et al. Association of arsenic, cadmium and manganese exposure with neurodevelopment and behavioural disorders in children: a systematic review and meta-analysis. Sci. Total Environ. (2013) 454–5:562–77. doi: 10.1016/j.scitotenv.2013.03.047
76. Yoshimasu K, Kiyohara C, Takemura S, Nakai K. A meta-analysis of the evidence on the impact of prenatal and early infancy exposures to mercury on autism and attention deficit/hyperactivity disorder in the childhood. Neurotoxicology. (2014) 44:121–31. doi: 10.1016/j.neuro.2014.06.007
77. Barbone F, Rosolen V, Mariuz M, Parpinel M, Casetta A, Sammartano F, et al. Prenatal mercury exposure and child neurodevelopment outcomes at 18 months: results from the mediterranean PHIME cohort. Int J Hyg Environ Health. (2019) 222:9–21. doi: 10.1016/j.ijheh.2018.07.011
78. Ryu J, Ha E-H, Kim B-N, Ha M, Kim Y, Park H, et al. Associations of prenatal and early childhood mercury exposure with autistic behaviors at 5 years of age: the Mothers and Children's Environmental Health (MOCEH) study. Sci Total Environ. (2017) 605:251–7. doi: 10.1016/j.scitotenv.2017.06.227
79. Vejrup K, Brandlistuen RE, Brantsæter AL, Knutsen HK, Caspersen IH, Alexander J, et al. Prenatal mercury exposure, maternal seafood consumption and associations with child language at five years. Environ Int. (2018) 110:71–9. doi: 10.1016/j.envint.2017.10.008
80. Wang Y, Chen L, Gao Y, Zhang Y, Wang C, Zhou Y, et al. Effects of prenatal exposure to cadmium on neurodevelopment of infants in Shandong, China. Environ Pollut. (2016) 211:67–73. doi: 10.1016/j.envpol.2015.12.038
81. Kippler M, Bottai M, Georgiou V, Koutra K, Chalkiadaki G, Kampouri M, et al. Impact of prenatal exposure to cadmium on cognitive development at preschool age and the importance of selenium and iodine. Eur J Epidemiol. (2016) 31:1123–34. doi: 10.1007/s10654-016-0151-9
82. Chatzi L, Ierodiakonou D, Margetaki K, Vafeiadi M, Chalkiadaki G, Roumeliotaki T, et al. Associations of prenatal exposure to cadmium with child growth, obesity, and cardiometabolic traits. Am J Epidemiol. (2019) 188:141–50. doi: 10.1093/aje/kwy216
83. Gustin K, Tofail F, Vahter M, Kippler M. Cadmium exposure and cognitive abilities and behavior at 10 years of age: a prospective cohort study. Environ Int. (2018) 113:259–68. doi: 10.1016/j.envint.2018.02.020
84. Moynihan M, Telléz-Rojo MM, Colacino J, Jones A, Song PXK, Cantoral A, et al. Prenatal cadmium exposure is negatively associated with adiposity in girls not boys during adolescence. Front Public Health. (2019) 12:61. doi: 10.3389/fpubh.2019.00061
85. Taylor CM, Kordas K, Golding J, Emond AM. Effects of low-level prenatal lead exposure on child IQ at 4 and 8 years in a UK birth cohort study. Neurotoxicology. (2017) 62:162–9. doi: 10.1016/j.neuro.2017.07.003
86. Shah-Kulkarni S, Ha M, Kim B-M, Kim E, Hong Y-C, Park H, et al. Neurodevelopment in early childhood affected by prenatal lead exposure and iron intake: medicine. (2016) 95:2508. doi: 10.1097/MD.0000000000002508
87. Silver MK, Li X, Liu Y, Li M, Mai X, Kaciroti N, et al. Low-level prenatal lead exposure and infant sensory function. Environ Health. (2016) 7:65. doi: 10.1186/s12940-016-0148-6
88. Farzan SF, Howe CG, Chen Y, Gilbert-Diamond D, Cottingham KL, Jackson BP, et al. Prenatal lead exposure and elevated blood pressure in children. Environ Int. (2018) 121:1289–96. doi: 10.1016/j.envint.2018.10.049
89. Polanska K, Hanke W, Pawlas N, Wesolowska E, Jankowska A, Jagodic M, et al. Sex-dependent impact of low-level lead exposure during prenatal period on child psychomotor functions. Int J Environ Res Public Health. (2018) 16:E2263. doi: 10.3390/ijerph15102263
90. Lyall K, Croen Lisa A, Sjödin A, Yoshida CK, Zerbo O, Kharrazi M, et al. Polychlorinated biphenyl and organochlorine pesticide concentrations in maternal mid-pregnancy serum samples: association with autism spectrum disorder and intellectual disability. Environ Health Perspect. (2017) 125:474–80. doi: 10.1289/EHP277
91. Tang-Péronard JL, Heitmann BL, Andersen HR, Steuerwald U, Grandjean P, Weihe P, et al. Association between prenatal polychlorinated biphenyl exposure and obesity development at ages 5 and 7 y: a prospective cohort study of 656 children from the Faroe Islands. Am J Clin Nutr. (2014) 99:5–13. doi: 10.3945/ajcn.113.066720
92. Doi H, Nishitani S, Fujisawa TX, Nagai T, Kakeyama M, Maeda T, et al. Prenatal exposure to a Polychlorinated Biphenyl (PCB) congener influences fixation duration on biological motion at 4-months-old: a preliminary study. PLoS ONE. (2013) 8:e59196. doi: 10.1371/journal.pone.0059196
93. Iszatt N, Stigum H, Verner M-A, White RA, Govarts E, Murinova LP, et al. Prenatal and postnatal exposure to persistent organic pollutants and infant growth: a pooled analysis of seven European birth cohorts. Environ Health Perspect. (2015) 123:730–6. doi: 10.1289/ehp.1308005
94. Berghuis SA, Soechitram SD, Hitzert MM, Sauer PJJ, Bos AF. Prenatal exposure to polychlorinated biphenyls and their hydroxylated metabolites is associated with motor development of three-month-old infants. Neurotoxicology. (2013) 38:124–30. doi: 10.1016/j.neuro.2013.07.003
95. Jung KH, Yan B, Moors K, Chillrud SN, Perzanowski MS, Whyatt RM, et al. Repeated exposure to polycyclic aromatic hydrocarbons and asthma: effect of seroatopy. Ann Allergy Asthma Immunol. (2012) 109:249–54. doi: 10.1016/j.anai.2012.07.019
96. Rundle A, Hoepner L, Hassoun A, Oberfield S, Freyer G, Holmes D, et al. Association of childhood obesity with maternal exposure to ambient air polycyclic aromatic hydrocarbons during pregnancy. Am J Epidemiol. (2012) 1:1163–72. doi: 10.1093/aje/kwr455
97. Edwards SC, Jedrychowski W, Butscher M, Camann D, Kieltyka A, Mroz E, et al. Prenatal exposure to airborne polycyclic aromatic hydrocarbons and children's intelligence at 5 years of age in a prospective cohort study in Poland. Environ Health Perspect. (2010) 118:1326–31. doi: 10.1289/ehp.0901070
98. Genkinger JM, Stigter L, Jedrychowski W, Huang T-J, Wang S, Roen EL, et al. Prenatal polycyclic aromatic hydrocarbon (PAH) exposure, antioxidant levels and behavioral development of children ages 6–9. Environ Res. (2015) 140:136–44. doi: 10.1016/j.envres.2015.03.017
99. Wild CP. Complementing the genome with an “Exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. (2005) 14:1847–50. doi: 10.1158/1055-9965.EPI-05-0456
100. Wild CP. The exposome: from concept to utility. Int J Epidemiol. (2012) 41:24–32. doi: 10.1093/ije/dyr236
101. Fleming TP, Watkins AJ, Velazquez MA, Mathers JC, Prentice AM, Stephenson J, et al. Origins of lifetime health around the time of conception: causes and consequences. Lancet. (2018) 391:1842–52. doi: 10.1016/S0140-6736(18)30312-X
102. Soares MJ, Varberg KM, Iqbal K. Hemochorial placentation: development, function, and adaptations. Biol Reprod. (2018) 99:196–211. doi: 10.1093/biolre/ioy049
103. Burton GJ, Fowden AL, Thornburg KL. Placental origins of chronic disease. Physiol Rev. (2016) 96:1509–65. doi: 10.1152/physrev.00029.2015
104. Rudge CV, Röllin HB, Nogueira CM, Thomassen Y, Rudge MC, Odland JØ. The placenta as a barrier for toxic and essential elements in paired maternal and cord blood samples of South African delivering women. J. Environ. Monit. (2009) 11:1322. doi: 10.1039/b903805a
105. Myllynen P, Immonen E, Kummu M, Vahakangas K. Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues. Expert Opin Drug Metab Toxicol. (2009) 5:1483–99. doi: 10.1517/17425250903304049
106. Heazell A. The placenta and adverse pregnancy outcomes – opening the black box? BMC Pregnancy Childbirth. (2015) 15:1471–2393. doi: 10.1186/1471-2393-15-S1-A5
107. Kippler M, Hoque AMW, Raqib R. Accumulation of cadmium in human placenta interacts with the transport of micronutrients to the fetus. Toxicol Lett. (2010) 192:162–8. doi: 10.1016/j.toxlet.2009.10.018
108. Fei DL, Koestler DC, Li Z, Giambelli C, Sanchez-Mejias A, Gosse JA, et al. Association between in Utero arsenic exposure, placental gene expression, and infant birth weight: a US birth cohort study. Environ Health. (2013) 16:12–58. doi: 10.1186/1476-069X-12-58
109. Everson TM, Kappil M, Hao K, Jackson BP, Punshon T, Karagas MR, et al. Maternal exposure to selenium and cadmium, fetal growth, and placental expression of steroidogenic and apoptotic genes. Environ Res. (2017) 158:233–44. doi: 10.1016/j.envres.2017.06.016
110. Deyssenroth MA, Gennings C, Liu SH, Peng S, Hao K, Lambertini L, et al. Intrauterine multi-metal exposure is associated with reduced fetal growth through modulation of the placental gene network. Environ Int. (2018) 120:373–81. doi: 10.1016/j.envint.2018.08.010
111. Ahmed S, Mahabbat-e Khoda S, Rekha RS, Gardner RM, Ameer SS, Moore S, et al. Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Environ Health Perspect. (2011) 119:258–64. doi: 10.1289/ehp.1002086
112. Lambertini L, Li Q, Ma Y, Zhang W, Hao K, Marsit C, et al. Placental imprinted gene expression mediates the effects of maternal psychosocial stress during pregnancy on fetal growth. J Dev Orig Health Dis. (2019) 10:1–10. doi: 10.1017/S2040174418000545
113. Kappil MA, Li Q, Li A, Dassanayake PS, Xia Y, Nanes JA, et al. In utero exposures to environmental organic pollutants disrupt epigenetic marks linked to fetoplacental development. Environ Epigenet. (2016) 2:dvv013. doi: 10.1093/eep/dvv013
114. Maccani JZ, Koestler DC, Lester B, Houseman EA, Armstrong DA, Kelsey KT, et al. Placental DNA methylation related to both infant toenail mercury and adverse neurobehavioral outcomes. Environ Health Perspect. (2015) 123:723–29. doi: 10.1289/ehp.1408561
115. Wright RJ. Moving towards making social toxins mainstream in children's environmental health/ Curr Opin Pediatr. (2009). 21:222–9. doi: 10.1097/MOP.0b013e3283292629
116. Borghol N, Suderman M, McArdle W, Racine A, Hallett M, Pembrey M, et al. Associations with early-life socio-economic position in adult DNA methylation. Int J Epidemiol. (2012) 41:62–74. doi: 10.1093/ije/dyr147
117. Fenech M, Ferguson LR. Vitamins/minerals and genomic stability in humans. Mutat Res. (2001) 475:1–6. doi: 10.1016/S0027-5107(01)00069-0
118. Cottrell EC, Holmes MC, Livingstone DE, Kenyon CJ, Seckl JR. Reconciling the nutritional and glucocorticoid hypotheses of fetal programming. FASEB J. (2012) 26:1866–74. doi: 10.1096/fj.12-203489
119. Yang K, Julan L, Rubio F, Sharma A, Guan H. Cadmium reduces 11 beta-hydroxysteroid dehydrogenase type 2 activity and expression in human placental trophoblast cells. Am J Physiol Endocrinol Metab. (2006) 290:E135–42. doi: 10.1152/ajpendo.00356.2005
120. Clougherty JE, Levy JI, Kubzansky LD, Ryan PB, Suglia SF, Canner MJ, et al. Synergistic effects of traffic-related air pollution and exposure to violence on urban asthma etiology. Environ Health Perspect. (2007) 115:1140–6. doi: 10.1289/ehp.9863
121. Mudu P, Terracini B, Martuzzi M. Human Health in Areas With Industrial Contamination. WHO (2014). p. 380. Available online at: http://www.euro.who.int/__data/assets/pdf_file/0006/264813/Human-Health-in-Areas-with-Industrial-Contamination-Eng.pdf (accessed April 2020).
122. Grosse SD, Matte TD, Schwartz J, Jackson RJ. Economic gains resulting from the reduction in children's exposure to lead in the United States. Environ Health Perspect. (2002) 110:563–69 doi: 10.1289/ehp.02110563
123. Tamayo-Uria I, Maitre L, Thomsen C, Nieuwenhuijsen MJ, Chatzi L, Siroux V, et al. The early-life exposome: description and patterns in six European countries. Environ Int. (2019) 123:189–200. doi: 10.1016/j.envint.2018.11.067
124. Sarigiannis D. Exposome science for public health protection and innovation. Toxicol Lett. (2015) 238:S12–3. doi: 10.1016/j.toxlet.2015.08.154
125. Sarigiannis DA, Karakitsios SP. Addressing complexity of health impact assessment in industrially contaminated sites via the exposome paradigm. Epidemiol Prev. (2018) 42:37–48. doi: 10.19191/EP18.5-6.S1.P037.086
126. Ruggieri S, Drago G, Colombo P, Alesci A, Augello P, Bisbano A, et al. Three contaminated sites in southern Italy. The Neonatal Environment and Health Outcomes cohort: protocol for a longitudinal birth cohort study. BMJ Open. (2019) 9:e029471. doi: 10.1136/bmjopen-2019-029471
127. United Nations Environment Programme. Report of the fourth session of the United Nations Environment Assembly of the United Nations Environment Programme.. Nairobi (2019). Available online at: http://wedocs.unep.org/bitstream/handle/20.500.11822/28468/K1901384.pdf?sequence=3&isAllowed=y (accessed April 2020).
Keywords: birth cohorts, highly contaminated sites, fetal exposome, DOHaD postulate, placenta, child growth
Citation: Drago G, Ruggieri S, Bianchi F, Sampino S and Cibella F (2020) Birth Cohorts in Highly Contaminated Sites: A Tool for Monitoring the Relationships Between Environmental Pollutants and Children's Health. Front. Public Health 8:125. doi: 10.3389/fpubh.2020.00125
Received: 08 July 2019; Accepted: 27 March 2020;
Published: 28 April 2020.
Edited by:
Mohiuddin Md. Taimur Khan, Washington State University Tri-Cities, United StatesReviewed by:
Soterios A. Kyrtopoulos, National Hellenic Research Foundation, GreeceNour Baïz, Institut National de la Santé et de la Recherche Médicale (INSERM), France
Copyright © 2020 Drago, Ruggieri, Bianchi, Sampino and Cibella. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Fabio Cibella, ZmFiaW8uY2liZWxsYSYjeDAwMDQwO2lyaWIuY25yLml0
†These authors have contributed equally to this work